Citicoline+Piracetam (Recogza-P)

RECOGZA-P – Citicoline 500 mg + Piracetam 800 mg

RECOGZA-P – Citicoline 500 mg + Piracetam 800 mg

The combination is generally prescribed for memory enhancement, neurological and cognitive disorder, Parkinsonism and Alzheimer disorder.

Overview

  • Established as effective initial monotherapy for children with partial-onset seizures1
  • First line drug for partial and secondarily generalized seizures 1
  • It is effective in patients with refractory generalized seizures2
  • It is well tolerated and has fewer drug- drug interaction compared to carbamazepine1

Ref:

1. Indian Pediatr. 2013 Nov 8;50(11):1033-40.

2. Sao Paulo Med J. 2009; 127(3):150-9.

3. Journal of Neuroscience and Behavioural Health, September 2010; 2(3):30-33